Phase 3 randomized study of the efficacy and safety of inhaled dry powder mannitol for the symptomatic treatment of non-cystic fibrosis bronchiectasis - Bilton, D; Daviskas, E; Anderson, S D; B301 Investigators (Chest, 2013)